nach oben

AIDS and Behavior

Erschienen in:

01.11.2006

The Impact of Syringe Deregulation on Sources of Syringes for Injection Drug Users: Preliminary Findings

verfasst von: Sherry Deren, Charles M. Cleland, Crystal Fuller, Sung-Yeon Kang, Don C. Des Jarlais, David Vlahov

Erschienen in: AIDS and Behavior | Ausgabe 6/2006

Einloggen, um Zugang zu erhalten

Abstract

In 2001, New York State enacted legislation to allow the provision of syringes by pharmacies and healthcare providers without prescription (ESAP, the Expanded Syringe Access Demonstration Program). A longitudinal study of IDUs (n=130) found that pre-ESAP, about half used only the safest source (needle exchange programs [NEPs]). Post-ESAP implementation, ESAP sources were initiated by 14%. Frequency of injection was related to ESAP use and those who used unsafe (or possibly unsafe) sources were as likely to use ESAP as those who had previously used only NEPs. The findings indicate that providing multiple sources of safe syringes for IDUs is necessary.

Carneiro, M., Fuller, C., Doherty, M., and Vlahov, D. (1999). HIV prevalence and risk behaviors among new initiates into injection drug use over the age of 40 years old. Drug and Alcohol Dependence, 54, 83–86.PubMedCrossRef

Center for Urban Epidemiologic Studies, New York Academy of Medicine, Beth Israel Medical Center, and National Development and Research Institutes, Inc. (2003). New York State Expanded Syringe Access Demonstration Program Evaluation. New York: New York Academy of Medicine.

Colón, H. M., Robles, R. R., Deren, S., Sahai, H., Finlingon, H., Andia, J., et al. (2003). Between-city variation in frequency of injection among Puerto Rican injection drug users: East Harlem, New York and Bayamon, Puerto Rico. Journal of Psychoactive Drugs, 35, 197–207.PubMed

Deren, S., Fuller, C., Pouget, E. R., Blaney, S., Tortu, S., Kang, S. Y., et al. (2003). Impact of expanding syringe access in New York on sources of syringes for injection drug users in Harlem and the Bronx, NYC, USA. International Journal of Drug Policy, 14, 373–379.CrossRef

Deren, S., Oliver-Velez, D., Finlinson, A., Robles, R. R., Andia, J., Colón, H. M., et al. (2003). Integrating qualitative and quantitative methods: comparing HIV-related risk behaviors among Puerto Rican drug users in Puerto Rico and New York. Substance Use and Misuse, 38, 1–24.PubMedCrossRef

Des Jarlais, D. C., Marmor, M., Friedmann, P., Titus, S., Aviles, E., Deren, S., et al. (2000). HIV incidence among injection drug users in New York City, 1992–1997: evidence for a declining epidemic. American Journal of Public Health, 90, 352–359.PubMedCrossRef

Des Jarlais, D. C., McKnight, C., and Friedmann, P. (2002). Legal syringe purchases by injection drug users, Brooklyn and Queens, New York City, 2000–2001. Journal of the American Pharmaceutical Association, 42 (Suppl. 2), S73–S76.PubMed

Fuller, C., Galea, S., Blaney, S., Ompad, D. C., Deren, S., Des Jarlais, D. C., et al. (2004). Explaining the relationship between race/ethnicity and pharmacy purchased syringes among injection drug users in New York City. Ethnicity and Disease, 14, 589–596.PubMed

Hagan, H., Thiede, H., and Des Jarlais, D. C. (2004). Hepatitis C virus infection among injection drug users: survival analysis of time to seroconversion. Epidemiology, 15, 543–549.PubMedCrossRef

Klein, S. J., Estel, G. R., Candelas, A. R., and Plavin, H. A. (2002). Promoting safe syringe disposal goes “hand in hand” with Expanded Syringe Access in New York State. Journal of the American Pharmaceutical Association, 42 (Suppl. 2), S29–S31.PubMed

Normand, J., Vlahov, D., and Moses, L. E. (eds.). (1995). Preventing HIV transmission: the role of sterile needles and bleach. Washington, DC: National Academy of Medicine.

Pouget, E. R., Deren, S., Fuller, C., Blaney, S., McMahon, J., Kang, S. Y., et al. (2005). Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. Journal of Acquired Immune Deficiency Syndromes, 39, 471–477.PubMedCrossRef

Titel: The Impact of Syringe Deregulation on Sources of Syringes for Injection Drug Users: Preliminary Findings
verfasst von: Sherry Deren
Charles M. Cleland
Crystal Fuller
Sung-Yeon Kang
Don C. Des Jarlais
David Vlahov
Publikationsdatum: 01.11.2006
Verlag: Kluwer Academic Publishers-Plenum Publishers
Erschienen in: AIDS and Behavior / Ausgabe 6/2006
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-006-9096-4

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

The Impact of Syringe Deregulation on Sources of Syringes for Injection Drug Users: Preliminary Findings

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

Neuer Myosin-Inhibitor bei hypertropher Kardiomyopathie von Nutzen

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

Update Innere Medizin

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2006

Assessing the Efficacy of a Voluntary HIV Counseling and Testing Intervention for Pregnant Women and Male Partners in Urumqi City, China

Providers’ HIV Prevention Discussions with HIV-Seropositive Injection Drug Users

I Can Use a Condom, I Just Don’t: The Importance of Motivation to Prevent HIV in Adolescent Seeking Psychiatric Care

Contextual Determinants of Condom Use Among Female Sex Exchangers in East Harlem, NYC: An Event Analysis

Examining the role of partner status in an HIV prevention trial targeting HIV-positive gay and bisexual men: the seropositive urban men’s intervention trial (SUMIT)

New York City Injection Drug Users’ Memories of Syringe-Sharing Patterns and Changes During the Peak of the HIV/AIDS Epidemic

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

Neuer Myosin-Inhibitor bei hypertropher Kardiomyopathie von Nutzen

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

Update Innere Medizin